Cargando…
Propranolol as therapy for cerebral cavernous malformations: a cautionary note
Autores principales: | Shenkar, Robert, Moore, Thomas, Benavides, Christian, Lightle, Rhonda, Detter, Matthew R., Hobson, Nicholas, Girard, Romuald, DeBiasse, Dorothy, Patrucco, Mary, Gallione, Carol, Zabramski, Joseph M., Marchuk, Douglas A., Awad, Issam A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8981698/ https://www.ncbi.nlm.nih.gov/pubmed/35382850 http://dx.doi.org/10.1186/s12967-022-03360-4 |
Ejemplares similares
-
Single-nucleus DNA sequencing reveals hidden somatic loss-of-heterozygosity in Cerebral Cavernous Malformations
por: Ressler, Andrew K., et al.
Publicado: (2023) -
Phenotypic Characterization of Murine Models of Cerebral Cavernous Malformations
por: Zeineddine, Hussein A., et al.
Publicado: (2018) -
Inflammatory Mechanisms in a Neurovascular Disease: Cerebral Cavernous Malformation
por: Li, Ying, et al.
Publicado: (2023) -
Developmental venous anomalies are a genetic primer for cerebral
cavernous malformations
por: Snellings, Daniel A., et al.
Publicado: (2022) -
Cerebral cavernous malformations are driven by ADAMTS5 proteolysis of versican
por: Hong, Courtney C., et al.
Publicado: (2020)